EPA:ALMDP - Euronext Paris - Matif - FR0010844464 - Common Stock - Currency: EUR
EPA:ALMDP (3/7/2025, 7:00:00 PM)
0.381
-0.01 (-2.31%)
The current stock price of ALMDP.PA is 0.381 EUR. In the past month the price decreased by -9.5%. In the past year, price decreased by -68.51%.
Medesis Pharma SA operates as a clinical development stage biopharmaceutical company, which engages in the research and development of orally administered molecule drugs. The company is headquartered in Baillargues, Occitanie. The company went IPO on 2021-02-12. The firm is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.
MEDESIS PHARMA SA
L'Oree des Mas Avenue du Golf, Montpellier
Baillargues OCCITANIE FR
Employees: 10
Company Website: https://www.medesispharma.com/
Investor Relations: http://www.medesispharma.com/ipo/
Phone: 33467030396
The current stock price of ALMDP.PA is 0.381 EUR. The price decreased by -2.31% in the last trading session.
The exchange symbol of MEDESIS PHARMA SA is ALMDP and it is listed on the Euronext Paris - Matif exchange.
ALMDP.PA stock is listed on the Euronext Paris - Matif exchange.
7 analysts have analysed ALMDP.PA and the average price target is 0.82 EUR. This implies a price increase of 114.17% is expected in the next year compared to the current price of 0.381. Check the MEDESIS PHARMA SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MEDESIS PHARMA SA (ALMDP.PA) has a market capitalization of 1.93M EUR. This makes ALMDP.PA a Nano Cap stock.
MEDESIS PHARMA SA (ALMDP.PA) currently has 10 employees.
MEDESIS PHARMA SA (ALMDP.PA) has a support level at 0.38 and a resistance level at 0.41. Check the full technical report for a detailed analysis of ALMDP.PA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALMDP.PA does not pay a dividend.
ChartMill assigns a technical rating of 3 / 10 to ALMDP.PA. When comparing the yearly performance of all stocks, ALMDP.PA is a bad performer in the overall market: 96.6% of all stocks are doing better.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 40% to ALMDP.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.